ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,277.51
0.80%
US Tech 100
18,064.80
0.02%
다우존스 지수
38,686.32
1.51%
Bitcoin
67,729.71
0.01%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Belite Bio Inc (BLTE)

  7. Belite Bio Inc (BLTE) 뉴스

BLTE

Belite Bio (BLTE)

Belite Bio Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:BLTE
일자시간출처헤드라인심볼기업
2024/05/3105:45Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
2024/05/1800:36Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
2024/05/1703:23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
2024/05/1421:00GlobeNewswire Inc.Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor ConferenceNASDAQ:BLTEBelite Bio Inc
2024/05/1410:57Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BLTEBelite Bio Inc
2024/05/1410:50GlobeNewswire Inc.Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:BLTEBelite Bio Inc
2024/05/1321:00GlobeNewswire Inc.Belite Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor ConferenceNASDAQ:BLTEBelite Bio Inc
2024/05/0821:00GlobeNewswire Inc.Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial ResultsNASDAQ:BLTEBelite Bio Inc
2024/05/0621:15GlobeNewswire Inc.Belite Bio to Participate in Key Opinion Leader Webinar to Discuss Unmet Needs In Stargardt Disease (STGD1) and Geographic Atrophy (GA) and Perspectives On TinlarebantNASDAQ:BLTEBelite Bio Inc
2024/05/0621:00GlobeNewswire Inc.Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at the ARVO Annual MeetingNASDAQ:BLTEBelite Bio Inc
2024/05/0205:15GlobeNewswire Inc.Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 Annual MeetingNASDAQ:BLTEBelite Bio Inc
2024/04/2608:15GlobeNewswire Inc.Belite Bio Announces $25 Million Registered Direct OfferingNASDAQ:BLTEBelite Bio Inc
2024/03/2221:00GlobeNewswire Inc.Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in JapanNASDAQ:BLTEBelite Bio Inc
2024/03/1211:28GlobeNewswire Inc.Belite Bio Announces Availability of Annual Report on Form 20-F Through Company WebsiteNASDAQ:BLTEBelite Bio Inc
2024/03/1210:27GlobeNewswire Inc.Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:BLTEBelite Bio Inc
2024/03/0622:00GlobeNewswire Inc.Belite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2024 Financial ResultsNASDAQ:BLTEBelite Bio Inc
2024/03/0422:00GlobeNewswire Inc.Belite Bio to Participate in the Leerink Partners Global Biopharma ConferenceNASDAQ:BLTEBelite Bio Inc
2024/02/1311:08Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BLTEBelite Bio Inc
2024/02/1310:40Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BLTEBelite Bio Inc
2024/02/0722:00GlobeNewswire Inc.Belite Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:BLTEBelite Bio Inc
2023/12/2906:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
2023/12/2906:15Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
2023/11/3022:00GlobeNewswire Inc.Belite Bio to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor ConferenceNASDAQ:BLTEBelite Bio Inc
2023/11/2907:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
2023/11/2022:00GlobeNewswire Inc.Belite Bio to Participate in the BTIG Ophthalmology DayNASDAQ:BLTEBelite Bio Inc
2023/11/1706:41Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
2023/11/1706:36Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
2023/11/1410:15GlobeNewswire Inc.Belite Bio Reports Third Quarter 2023 Operational Highlights and Financial ResultsNASDAQ:BLTEBelite Bio Inc
2023/11/1022:35GlobeNewswire Inc.Deutsche Bank ADR Investor Conference: Presentations Now Available for Online ViewingNASDAQ:BLTEBelite Bio Inc
2023/11/0722:00GlobeNewswire Inc.Belite Bio to Host Webcast on November 14, 2023, to Discuss Third Quarter 2023 Financial ResultsNASDAQ:BLTEBelite Bio Inc
 검색 관련기사 보기:NASDAQ:BLTE

최근 히스토리

USOTC
RHHBY
Roche (QX)
NYSE
NKE
Nike
NYSE
VZ
Verizon Communications
NYSE
MRK
Merck
USOTC
DTEGY
Deutsche Telekom (QX)
COIN
ETHUSD
Ethereum
CCOM
SILVER
SILVER
FX
USDJPY
US Dollar vs Yen
COIN
SOLUSD
Solana
NYSE
XOM
Exxon Mobil
USOTC
BASFY
BASF (QX)
NASDAQ
NVDA
NVIDIA
NASDAQ
AAPL
Apple
NASDAQ
MSFT
Microsoft
AMEX
XLV
Health Care Select Sector
NYSE
BAC
Bank of America
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유